FindTrial
Sign In

Research on immune target therapy for children with leukemia

Research on the critical technique in the individualized therapy for children with acute lymphocytic leukemia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-08000077
Enrollment
Unknown
Registered
2008-04-08
Start date
2008-06-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Childhood acute leukemia

Interventions

Childhood leukemia patients:Culture the collected bone marrow and them in vitro and give re-transfusion therapy after inducing the proliferation of donor-specific T cell in vitro

Sponsors

Beijing Children's Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 15 Years

Inclusion criteria

Inclusion criteria: Refractory and relapsed childhood acute leukemia and improper for conventional chemotherapy or bone marrow transplantation.

Exclusion criteria

Exclusion criteria: Childhood leukemia suited for conventional chemotherapy or bone marrow transplantation.

Design outcomes

Primary

MeasureTime frame
Enriched specific T cell;—

Secondary

MeasureTime frame
Relief status;—

Countries

China

Contacts

Public ContactHuyong Zheng
zhenghuyong@vip.sina.com+86 010 13910634468

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026